AtriCure (ATRC) Common Equity (2016 - 2025)
Historic Common Equity for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $476.5 million.
- AtriCure's Common Equity rose 247.0% to $476.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $476.5 million, marking a year-over-year increase of 247.0%. This contributed to the annual value of $461.0 million for FY2024, which is 111.53% down from last year.
- Latest data reveals that AtriCure reported Common Equity of $476.5 million as of Q3 2025, which was up 247.0% from $464.5 million recorded in Q2 2025.
- AtriCure's 5-year Common Equity high stood at $488.5 million for Q3 2021, and its period low was $385.1 million during Q2 2021.
- Over the past 5 years, AtriCure's median Common Equity value was $462.1 million (recorded in 2024), while the average stood at $455.9 million.
- Its Common Equity has fluctuated over the past 5 years, first surged by 7207.63% in 2021, then crashed by 781.24% in 2022.
- Over the past 5 years, AtriCure's Common Equity (Quarter) stood at $483.8 million in 2021, then dropped by 5.58% to $456.8 million in 2022, then grew by 2.06% to $466.2 million in 2023, then dropped by 1.12% to $461.0 million in 2024, then grew by 3.37% to $476.5 million in 2025.
- Its Common Equity stands at $476.5 million for Q3 2025, versus $464.5 million for Q2 2025 and $454.6 million for Q1 2025.